Phospholipase D modulation by ceramide in senescence.
Phospholipase D (PLD) has been implicated in mitotic regulation and has been shown to be defective in cells following replicative senescence. We examined the source of changes in PLD activity in senescent human umbilical vein endothelial cells and in human diploid fibroblasts. Using fractionated cell components we found that the cytosolic components were necessary for maximum PLD activation. In comparison to low-passage cells, senescent cells showed a profound lack of PLD activatability. By recombining fractionated components from senescent and low-passage cells, we found that in senescence the membrane component is defective in activating PLD implicating either the PLD enzyme itself or its interaction with PKC and/or ARF. The sphingolipid ceramide has been implicated in mediating senescence. Treatment with ceramide resulted in a decrease in PLD activity, implicating ceramide as the mediator of the inhibition.
Biology Department, Appalachian State University, Boone, NC 28608-2027, USA.
Lisa M
LM
Webb
Alan T
AT
Arnholt
Mark E
ME
Venable
D002452:Cell Count; D002457:Cell Extracts / Q000494:pharmacology; D002458:Cell Fractionation; D002462:Cell Membrane / Q000737:chemistry / Q000502:physiology; D002478:Cells, Cultured; D016922:Cellular Senescence / Q000187:drug effects* / Q000502:physiology; D002518:Ceramides / Q000494:pharmacology*; D003600:Cytosol / Q000737:chemistry / Q000502:physiology; D004305:Dose-Response Relationship, Drug; D004789:Enzyme Activation / Q000187:drug effects; D004791:Enzyme Inhibitors / Q000494:pharmacology; D006801:Humans; D010739:Phospholipase D / Q000037:antagonists & inhibitors / Q000378:metabolism*
D002457:Cell Extracts; D002518:Ceramides; D004791:Enzyme Inhibitors; C101954:N-caproylsphingosine; D010739:Phospholipase D